Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth A Brodie

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Expert Review of Anticancer Therapy|July 15, 2014
Could valproic acid be an effective anticancer agent? The evidence so farSeth A Brodie, Johann C Brandes
Respiratory Medicine|December 6, 2014
Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) projectSeth A Brodie, Ge Li, Johann C Brandes
Therapeutic Advances in Respiratory Disease|July 7, 2011
Targeted therapy of non-small-cell lung carcinomaDivya Tiwari, Seth A Brodie, Johann C Brandes
Molecular and Cellular Biology|December 2, 2004
Amino acid substitutions in yeast TFIIF confer upstream shifts in transcription initiation and altered interaction with RNA polymerase IIMohamed A Ghazy, Seth A Brodie, Michelle L Ammerman, et al.
Oncotarget|September 11, 2015
Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancerSeth A Brodie, Ge Li, Donald Harvey, et al.
Plos One|September 16, 2014
Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLCSeth A Brodie, Courtney Lombardo, Ge Li, et al.
Molecular Vision|October 22, 2020
An optimized protocol for retina single-cell RNA sequencingBenjamin R Fadl, Seth A Brodie, Michael Malasky, et al.
Cancer|March 26, 2014
Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancerHyunseok Kang, Theresa W Gillespie, Michael Goodman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 21, 2014
Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancerSeth A Brodie, Ge Li, Adam El-Kommos, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 6, 2013
Anti-inflammatory and antiatherogenic role of BMP receptor II in endothelial cellsChan Woo Kim, Hannah Song, Sandeep Kumar, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Review of Anticancer Therapy|July 15, 2014
Could valproic acid be an effective anticancer agent? The evidence so farSeth A Brodie, Johann C Brandes
Respiratory Medicine|December 6, 2014
Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) projectSeth A Brodie, Ge Li, Johann C Brandes
Therapeutic Advances in Respiratory Disease|July 7, 2011
Targeted therapy of non-small-cell lung carcinomaDivya Tiwari, Seth A Brodie, Johann C Brandes
Molecular and Cellular Biology|December 2, 2004
Amino acid substitutions in yeast TFIIF confer upstream shifts in transcription initiation and altered interaction with RNA polymerase IIMohamed A Ghazy, Seth A Brodie, Michelle L Ammerman, et al.
Oncotarget|September 11, 2015
Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancerSeth A Brodie, Ge Li, Donald Harvey, et al.
Plos One|September 16, 2014
Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLCSeth A Brodie, Courtney Lombardo, Ge Li, et al.
Molecular Vision|October 22, 2020
An optimized protocol for retina single-cell RNA sequencingBenjamin R Fadl, Seth A Brodie, Michael Malasky, et al.
Cancer|March 26, 2014
Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancerHyunseok Kang, Theresa W Gillespie, Michael Goodman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 21, 2014
Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancerSeth A Brodie, Ge Li, Adam El-Kommos, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 6, 2013
Anti-inflammatory and antiatherogenic role of BMP receptor II in endothelial cellsChan Woo Kim, Hannah Song, Sandeep Kumar, et al.
Pageof 2